Both C3a and Asp promote the expression of Gly-tRFs via mediating the expression of CYP2E1, which contributes to the development of liver steatosis by regulating Sirt1 expression (Fig. 6f). The gene discussed is CYP2E1; the disease is Hepatic steatosis.